<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>CAT-Site</dc:title><dc:creator>Hafner Petrovski,	Žan	(Avtor)
	</dc:creator><dc:creator>Hribar-Lee,	Barbara	(Avtor)
	</dc:creator><dc:creator>Bosnić,	Zoran	(Avtor)
	</dc:creator><dc:subject>protein binding site prediction</dc:subject><dc:subject>ligands</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>machine learning</dc:subject><dc:subject>convolutional neural network</dc:subject><dc:description>Identifying binding sites on the protein surface is an important part of computer-assisted drug design processes. Reliable prediction of binding sites not only assists with docking algorithms, but it can also explain the possible side-effects of a potential drug as well as its efficiency. In this work, we propose a novel workflow for predicting possible binding sites of a ligand on a protein surface. We use proteins from the PDBbind and sc-PDB databases, from which we combine available ligand information for similar proteins using all the possible ligands rather than only a special sub-selection to generalize the work of existing research. After performing protein clustering and merging of ligands of similar proteins, we use a three-dimensional convolutional neural network that takes into account the spatial structure of a protein. Lastly, we combine ligandability predictions for points on protein surfaces into joint binding sites. Analysis of our model’s performance shows that its achieved sensitivity is 0.829, specificity is 0.98, and F$_1$ score is 0.517, and that for 54% of larger and pharmacologically relevant binding sites, the distance between their real and predicted centers amounts to less than 4 Å.</dc:description><dc:date>2022</dc:date><dc:date>2024-01-25 15:17:10</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>154114</dc:identifier><dc:identifier>UDK: 004.8:615</dc:identifier><dc:identifier>ISSN pri članku: 1999-4923</dc:identifier><dc:identifier>DOI: 10.3390/pharmaceutics15010119</dc:identifier><dc:identifier>COBISS_ID: 135845635</dc:identifier><dc:language>sl</dc:language></metadata>
